Ling Liu

This inventor holds 15 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 8 EPO patents. Top assignees: Eli Lilly and Company, Amgen Inc., Imclone LLC. Active years: 2006-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ling Liu. Retrieved from https://idiyas.com/inventor/ling-liu-psfh921i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 1)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 10)

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 67(Granted Patents)

Location History:

Carmel, IN (US) (2006 - 2021)
Thousand Oaks, CA (US) (2021 - 2024)

Company Filing History:

11 out of 4,514

Eli Lilly and Company

Years Active: 2006-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11919964 - Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof (2024-03-05),

2. 11167039 - MET antibody drug conjugates (2021-11-09),

3. 10934362 - Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof (2021-03-02),

4. 9670284 - Therapeutic uses for VEGFR1 antibodies (2017-06-06),

5. 9580499 - VEGFR2/Ang2 compounds (2017-02-28),

6. 9328173 - Multifunctional antibodies binding to EGFR and MET (2016-05-03),

7. 9260531 - Anti-c-met antibodies (2016-02-16),

8. 9201074 - Anti-c-Met antibodies (2015-12-01),

9. 8398974 - c-Met antibodies (2013-03-19),

10. 8217148 - c-Met antibodies (2012-07-10),

11. 8182815 - Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment (2012-05-22),

12. 8110191 - Anti-IL-17 antibodies (2012-02-07),

13. 8043618 - Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment (2011-10-25),

14. 7838638 - Anti-IL-17 antibodies (2010-11-23),

15. 7101539 - Use of LP82 to treat hematopoietic disorders (2006-09-05),

Title: Ling Liu: Pioneering Innovations in Biotechnology

Introduction:

Renowned for her groundbreaking work in the field of biotechnology, Ling Liu has captivated the world with her passion for innovation and unwavering commitment to technological advancement. Her journey as an inventor has inspired countless individuals to redefine the boundaries of possibility and create a brighter future through their inventions.

Latest Patents:

Ling Liu's prolific career is highlighted by her impressive portfolio of 13 patents, with her most recent inventions making significant strides in the realm of cancer treatment and chronic kidney disease. Her groundbreaking work on MET antibody-drug conjugates demonstrates a novel approach to targeting MET-expressing tumor cells, offering new hope in the fight against cancer. Additionally, her therapeutic application of VEGFR1 antibodies showcases her dedication to revolutionizing the treatment of chronic kidney disease.

Career Highlights:

Having made invaluable contributions to the field of biotechnology, Ling Liu has garnered acclaim for her tenure at esteemed companies such as Eli Lilly and Company and Imclone LLC. Her innovative spirit and unwavering dedication to pushing the boundaries of technology have established her as a prominent figure in the industry, with her patent portfolio serving as a testament to her ingenuity and expertise.

Collaborations:

Throughout her illustrious career, Ling Liu has had the privilege of collaborating with esteemed colleagues such as Jirong Lu and Julian Davies. These partnerships have not only enriched her own inventive endeavors but have also fostered an environment of collaboration and knowledge-sharing within the industry, paving the way for future breakthroughs and advancements.

Conclusion:

In conclusion, Ling Liu's remarkable journey as an inventor epitomizes the transformative power of innovation and the boundless potential of human creativity. Through her pioneering work in biotechnology, she has redefined what is possible in the realm of inventions, inspiring a new generation of inventors and entrepreneurs to think boldly and forge a path towards a brighter and more prosperous future.

Profile summary based on public USPTO records.